Archive for the ‘Uncategorized’ Category

Business development

MSI will build broad usage of the RCATâ„¢ platform and other core technologies through the development of superior diagnostic and genomics tools. To accomplish this, we will pursue vigorous internal development and the establishment of strategic collaborations and licensing agreements to popularize the company's technology base. (more...)

Proteomics

rcatschematic2
If your scientific goals include biomarker discovery, validation, or assessing drug response, coverage is vital. MSI offers ultra-multiplexed protein analysis designed to yield a comprehensive look at the biology underlying disease and drug response.
(more...)

Other MSI Technologies

In addition to RCATTM and MDA MSI has exclusively licensed from Yale University the worldwide rights to two technologies: allele frequency distortion (AFD) and multiparametric fluorescent in-situ hybridization (MFISHTM). These additional technologies increase opportunities to develop new platforms, products and services.
Read the rest of this entry »